Multi-Reader Study of a fully automated artificial intelligence solution for HER2 scoring in breast cancer

Multi-site European study of a fully automated AI solution for HER2 scoring in breast cancer

AI for primary diagnosis: going beyond cancer detection (USCAP 2024)

The next generation of AI technology for interpretation of HER2 Low and practical application in the real-world setting (USCAP 2024)

USCAP 2024: Evaluating an AI Solution for detection of gastric cancer, helicobacter pylori, and other lesions in gastric biopsies

USCAP 2024: Utilization of Artificial Intelligence for the identification of microinvasive carcinoma of the breast

USCAP 2024: Validation and clinical implementation of an Artificial Intelligence solution for assisting diagnosis of microcalcifications in breast biopsies

USCAP 2024: Artificial Intelligence based detection of lobular neoplasia in breast biopsies

USCAP 2024: Automated classification of breast lesions using an AI-based approach

USCAP 2024: Routine use of an artificial intelligence solution for primary diagnosis of prostate biopsies in clinical practice

Dr. Tim Bracey: The Coastal Path to Artificial Intelligence in Digital Pathology

KLAS First Look Performance Report – Ibex Medical Analytics 2023